|
Volumn 378, Issue 8, 2018, Pages 693-695
|
Our other prescription drug problem
a a b |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPRAZOLAM;
BENZODIAZEPINE DERIVATIVE;
BUPRENORPHINE;
CLONAZEPAM;
DIAMORPHINE;
ESZOPICLONE;
FENTANYL;
ILLICIT DRUG;
LORAZEPAM;
METHADONE;
NARCOTIC ANALGESIC AGENT;
ZOLPIDEM;
ACCIDENTAL INJURY;
ALCOHOL WITHDRAWAL SYNDROME;
BEHAVIOR DISORDER;
DEPRESSION;
DISEASE EXACERBATION;
DRUG COST;
DRUG DEALING;
DRUG DEPENDENCE;
DRUG FATALITY;
DRUG LABELING;
DRUG MISUSE;
DRUG MONITORING;
DRUG OVERDOSE;
DRUG TOLERANCE;
DRUG UTILIZATION;
EMERGENCY CARE;
FALLING;
HOSPITAL ADMISSION;
HUMAN;
INAPPROPRIATE PRESCRIBING;
INSOMNIA;
OFF LABEL DRUG USE;
OPIATE ADDICTION;
PRIORITY JOURNAL;
RESTLESS LEGS SYNDROME;
REVIEW;
SEIZURE;
EPIDEMIOLOGY;
HEALTH SERVICE;
MORTALITY;
PRESCRIPTION DRUG MISUSE;
PREVENTION AND CONTROL;
TRENDS;
UNITED STATES;
BENZODIAZEPINES;
HUMANS;
MEDICAL OVERUSE;
PRESCRIPTION DRUG MISUSE;
SUBSTANCE-RELATED DISORDERS;
UNITED STATES;
|
EID: 85042607245
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMp1715050 Document Type: Review |
Times cited : (128)
|
References (5)
|